XenoPort’s CEO retires amid broader restructuring

XenoPort Inc.’s chief executive steps down as part of a broader restructuring that will eliminate about 25 jobs as the biopharmaceutical company focuses on its treatment for restless leg syndrome, the company said Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.